The 2nd Annual Innovation Forum at the 2016 ISPE Annual Meeting & Expo will bring together all levels of pharmaceutical professionals to discuss global challenges and opportunities for the adoption of emerging technologies and innovative approaches in pharmaceutical engineering. Take advantage of this unique occasion to talk through and learn about different perspectives on key concepts and developments within the industry. Presentations and discussions will focus on:
Register today to take advantage of these eight interactive Innovation Forum sessions including:
Get more details about the Innovation Forum and view the complete conference program. Join ISPE today and save hundreds of dollars on registration as well as enjoying other great membership benefits. See what insight Joe Famulare, Chair, ISPE Board of Directors, has on the education tracks for this year's conference.
In the pharmaceutical industry, which is highly regulated, aseptic processing is a critical component that ensures the sterility of products. Regulators have a set of comprehensive requirements that minimize the risk of contamination. Regulators set the requirements; however, the industry has an obligation to the patients who rely on and expect a drug that is safe and free of contamination....
Like any investment in digital manufacturing systems, demonstrating business payback before and after investment is critical to getting MES projects approved and verifying profitability after investment. Whether it is introducing MES, expanding it to additional sites, switching software, upgrading existing software, or developing electronic production records (EPR) for new drug products,...
Sustainability is emerging as a pivotal force influencing the pharmaceutical industry’s dynamics and steering companies towards transformative change. The focus of this analysis is to delve into the sustainability key performance indicators (KPIs) of prominent pharmaceutical players, namely Pfizer, Sanofi, Glaxo Smith Kline (GSK), Becton Dickinson, Johnson & Johnson, Abbott, Eli Lilly, and...